Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CR Bard completes MedChem Products takeover:

This article was originally published in Clinica

Executive Summary

CR Bard has completed the takeover of MedChem Products, announced in May (see Clinica No 657, p 11). MedChem shareholders will receive one Bard share per 3.25 MedChem shares. MedChem's Gesco line of vascular access catheters will become part of Bard Access Systems division, headquartered in Salt Lake City, Utah. MedChem Products will retain the haemostasis and wound closure products and operate as a new Bard division with headquarters in Woburn, Massachusetts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093515

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel